Find Resources
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study
According to recent data from the Centers for Disease Control and Prevention (CDC), the percentage of individuals reporting Long COVID symptoms has decreased from 19% in June 2022 to 11% in January 2023 among those who have had COVID-19. While this decline is notable, 15% of all US adults have reported experiencing Long COVID symptoms at some point, with 6% currently affected. Long COVID continues to pose challenges, including limitations in daily activities for 79% of those affected and potential long-term disabilities. Efforts to address Long COVID include research initiatives and public health actions, but its full impact and the reasons behind the decline in reported cases remain subjects of ongoing study and concern.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study, Summary Report/Recommendations
The guidance outlined in this report provides a roadmap for the ethical inclusion of pregnant women’s experiences in in the development and deployment of vaccines against emerging viruses. Recommendations include bolstering health information surveillance systems, stakeholder engagement with health care, women, families and communities, and changing the narrative about pregnancy and clinical research efforts. Recommendations require commitment of financial resources, addressing inequities in public health and whenever possible, the inclusion of perspectives of pregnant women. Lastly, the authors recommend that “When there is a limited supply of vaccine against a pathogenic threat that disproportionately affects pregnant women, their offspring, or both, or when only one vaccine among several is appropriate for use in pregnancy, then pregnant women should be among the priority groups to be offered the vaccine.” This prioritization process is key to addressing inequities and are guidance for future pandemic response efforts.